Current Neuro-Oncology
Volume
24 Number 1
15 January 2022
Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 1, 15 January
Aabedi
AA, Young JS, Zhang Y, Ammanuel S, Morshed RA, Dalle Ore C, Brown
D, Phillips JJ, Oberheim Bush NA, Taylor JW, Butowski N, Clarke J,
Chang SM, Aghi M, Molinaro AM, Berger MS, Hervey-Jumper
SL.
Association
of Neurological
Impairment
on the Relative Benefit of Maximal Extent of Resection in
Chemoradiation-Treated
Newly Diagnosed Isocitrate Dehydrogenase Wild-Type
Glioblastoma.
Neurosurgery.
2022 Jan 1;90(1):124-13∟.
doi: 10.1227/NEU.000000000000175∟.
PMID: 34982879∟.
Observational
study˰ ˍ
Hargreave
M, Mørch LS, Winther JF, Schmiegelow K, Kjaer
SK.
Association
Between
Maternal Hormonal Contraception Use and Central Nervous System
Tumors in
Children.
JAMA.
2022 Jan 4;327(1):59-66∟.
doi: 10.1001/jama.2021.22482∟.
PMID:
34982120∟.
Observational
study˰
ˍ
Kawauchi
D, Ohno M, Honda-Kitahara M, Miyakita Y, Takahashi M, Yanagisawa
S, Tamura Y, Kikuchi M, Ichimura K, Narita Y.
The
clinical characteristics and
outcomes
of incidentally discovered glioblastoma.
J
Neurooncol. 2022 Jan 5∟.
doi: 10.1007/s11060-021-03931-3∟.
PMID: 34985720∟.
Observational
study˰ ˍ
Salas
LA, Stewart TG, Mobley BC, Peng C, Liu J, Loganathan SN, Wang J,
Ma Y, Berger MS, Absher D, Hu Y, Moots PL, Christensen BC, Clark
SW.
Phase
I Study of High-Dose L-methylfolate in Combination with
Temozolomide and Bevacizumab in Recurrent IDH wild-type High-Grade
Glioma.
Cancer
Res Commun. 2022 Jan 5;2(1):1-9∟.
doi: 10.1158/2767-9764.CRC-21-0088∟.
PMID: 35392283∟.
Interventional study. ˍ
Grimaldi
S, Harlay V, Appay R, Bequet C, Petrirena G, Campello C, Barrié
M, Autran D, Boissonneau S, Graillon T, Figarella-Branger D, Nanni
I, Chinot O, Tabouret E.
Adult
H3K27M mutated thalamic glioma patients display a better
prognosis
than unmutated patients.
J
Neurooncol. 2022 Jan 7∟.
doi: 10.1007/s11060-022-03943-7∟.
PMID: 34994963∟.
Observational
study˰ ˍ
Kilian
A, Aigner A, Simon M, Salchow DJ, Potratz C, Thomale UW, Hernáiz
Driever P, Tietze A.
Tumor
load rather than contrast enhancement is associated
with
the visual function of children and adolescents with optic pathway
glioma -a retrospective Magnetic Resonance Imaging study.
J
Neurooncol. 2022 Jan 7∟.
doi: 10.1007/s11060-021-03941-1∟.
PMID: 34994964∟.
Observational
study. ˍ
Dono
A, Zhu P, Holmes E, Takayasu T, Zhu JJ, Blanco AI, Hsu S,
Bhattacharjee MB, Ballester LY, Kim DH, Esquenazi Y, Tandon
N.
Impacts
of genotypic variants
on
survival following reoperation for recurrent glioblastoma.
J
Neurooncol. 2022 Jan 8∟.
doi: 10.1007/s11060-021-03917-1∟.
PMID: 34997451∟.
Observational
study˰ ˍ
Schiavolin
S, Mariniello A, Broggi M, DiMeco F, Ferroli P, Leonardi
M.
Preoperative
nonmedical predictors of functional impairment after brain tumor
surgery.
Support
Care Cancer. 2022 Jan 9∟.
doi: 10.1007/s00520-021-06732-6∟.
PMID: 34999949∟.
Observational
study˰
ˍ
Peters
KB, Affronti ML, Woodring S, Lipp E, Healy P, Herndon JE 2nd,
Miller ES, Freeman MW, Randazzo DM, Desjardins A, Friedman
HS.
Effects
of low-dose
naltrexone
on quality of life in high-grade glioma patients: a
placebo-controlled, double-blind randomized trial.
Support
Care Cancer. 2022 Jan 10∟.
doi: 10.1007/s00520-021-06738-0∟.
PMID: 35001215∟.
Interventional study˰ ˍ
*
Xie
XP, Laks DR, Sun D, Ganbold M, Wang Z, Pedraza AM, Bale T, Tabar
V, Brennan
C, Zhou X, Parada LF.
Quiescent
human glioblastoma cancer stem cells
drive
tumor initiation, expansion, and recurrence following
chemotherapy.
Dev
Cell.
2022 Jan 10;57(1):32-46.e8∟.
doi: 10.1016/j.devcel.2021.12.007∟.
PMID: 35016005∟.
Laboratory
investigation˰ ˍ
Dono
F, Consoli S, Evangelista G, Ricci A, Russo M, Carrarini C, Di
Iorio A, Bonanni L, Anzellotti F, Onofrj M, Sensi
SL.
Levetiracetam
Prophylaxis Therapy
for
Brain Tumor-Related Epilepsy (BTRE) Is Associated With a Higher
Psychiatric
Burden.
Front
Neurol. 2022 Jan 11;12:806839∟.
doi: 10.3389/fneur.2021.806839∟.
PMID: 35087476∟.
Observational study. ˍ
Zaman
FY, McLean C, Ameratunga M.
Dramatic
clinical response in the treatment
of
small cell glioblastoma multiforme.
J
Clin Pharm Ther. 2022 Jan 11∟.
doi: 10.1111/jcpt.13608∟.
PMID: 35018664∟.
Case
report. ˍ
Iuchi
T, Inoue A, Hirose Y, Morioka M, Horiguchi K, Natsume A, Arakawa
Y, Iwasaki K, Fujiki M, Kumabe T, Sakata Y.
Long-term
effectiveness of Gliadel
implant
for malignant glioma and prognostic factors for survival: 3-year
results of
a postmarketing surveillance in Japan.
Neurooncol
Adv. 2022 Jan 12;4(1):vdab189∟.
doi: 10.1093/noajnl/vdab189∟.
PMID: 35118382∟.
Observational study. ˍ
Yamamoto
S, Sanada T, Sakai M, Arisawa A, Kagawa N, Shimosegawa E,
Nakanishi K, Kanemura Y, Kinoshita M, Kishima H.
Prediction
and Visualization of Non-Enhancing Tumor in Glioblastoma via
T1w/T2w-Ratio Map.
Brain
Sci. 2022 Jan 12;12(1):99∟.
doi: 10.3390/brainsci12010099∟.
PMID: 35053842∟.
Observational study. ˍ
*
Bruil
DE, David S, Nagtegaal SHJ, de Sonnaville SFAM, Verhoeff
JJC.
Irradiation
of the subventricular zone and subgranular zone in high- and
low-grade glioma patients: an atlas-based analysis on overall
survival.
Neurooncol
Adv. 2022 Jan 13;4(1):vdab193∟.
doi: 10.1093/noajnl/vdab193∟.
PMID: 35128399∟.
Observational study. ˍ
Metz
G, Jayamanne D, Wheeler H, Wong M, Cook R, Little N, Parkinson J,
Kastelan
M, Brown C, Back M.
Large
tumour volume reduction of IDH-mutated
anaplastic
glioma involving the insular region
following
radiotherapy.
BMC
Neurol.
2022 Jan 13;22(1):24∟.
doi: 10.1186/s12883-021-02548-3∟.
PMID: 35027006∟.
Observational study. ˍ
Alaña
L, Nunes-Xavier CE, Zaldumbide L, Martin-Guerrero I, Mosteiro L,
Alba-Pavón P, Villate O, García-Obregón S,
González-García H, Herraiz R, Astigarraga I, Pulido
R, García-Ariza M.
Identification
and Functional Analysis of a Novel
CTNNB1
Mutation
in Pediatric Medulloblastoma.
Cancers
(Basel). 2022 Jan 14;14(2):421∟.
doi: 10.3390/cancers14020421∟.
PMID: 35053583∟.
Laboratory investigation. ˍ
Mançano
BM, Dos Reis MB, Moreno DA, de Paula FE, de Almeida Junior CR,
Cavalcante CEB, Zanon MF, Santana IVV, Matsushita MM, Reis RM.
A
Unique Case
Report
of Infant-Type Hemispheric Glioma (Gliosarcoma Subtype) with
TPR-NTRK1 Fusion
Treated with Larotrectinib.
Pathobiology.
2022 Jan 14, 2022:1-8∟.
doi: 10.1159/000521253∟.
PMID: 35034013∟.
Case report˰ ˍ
Mijderwijk
HJ, Nieboer D, Incekara F, Berger K, Steyerberg EW, van den Bent
MJ, Reifenberger G, Hänggi D, Smits M, Senft C, Rapp M, Sabel
M, Voss M, Forster MT, Kamp MA.
Development
and external validation of a clinical prediction model
for
survival in patients with IDH wild-type glioblastoma.
J
Neurosurg. 2022 Jan 14, 2022:1-10∟.
doi: 10.3171/2021.10.JNS211261∟.
PMID: 35171829∟.
Observational study˰ ˍ
*
Dadario
NB, Zaman A, Pandya M, Dlouhy BJ, Gunawardena MP, Sughrue ME, Teo
C.
Endoscopic-assisted
surgical approach for butterfly glioma surgery.
J
Neurooncol. 2022 Jan 15∟.
doi: 10.1007/s11060-022-03945-5∟.
PMID: 35032284∟.
Observational study˰ ˍ